期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals 被引量:14
1
作者 Fan Zhang Rui Gan +9 位作者 ziqi zhen Xiaoli Hu Xiang Li Fengxia Zhou Ying Liu Chuangeng Chen Shuangyu Xie Bailing Zhang Xiaoke Wu Zhiwei Huang 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2020年第1期1123-1133,共11页
The global Coronavirus disease 2019(COVID-19)pandemic caused by SARS-CoV-2 has affected more than eight million people.There is an urgent need to investigate how the adaptive immunity is established in COVID-19 patien... The global Coronavirus disease 2019(COVID-19)pandemic caused by SARS-CoV-2 has affected more than eight million people.There is an urgent need to investigate how the adaptive immunity is established in COVID-19 patients.In this study,we proled adaptive immune cells of PBMCs from recovered COVID-19 patients with varying disease severity using single-cell RNA and TCR/BCR V(D)J sequencing.The sequencing data revealed SARS-CoV-2-specic shufing of adaptive immune repertories and COVID-19-induced remodeling of peripheral lymphocytes.Characterization of variations in the peripheral T and B cells from the COVID-19 patients revealed a positive correlation of humoral immune response and T-cell immune memory with disease severity.Sequencing and functional data revealed SARS-CoV-2-specic T-cell immune memory in the convalescent COVID-19 patients.Furthermore,we also identied novel antigens that are responsive in the convalescent patients.Altogether,our study reveals adaptive immune repertories underlying pathogenesis and recovery in severe versus mild COVID-19 patients,providing valuable information for potential vaccine and therapeutic development against SARS-CoV-2 infection. 展开更多
关键词 IMMUNITY SEVERITY VACCINE
原文传递
Correction to: Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals
2
作者 Fan Zhang Rui Gan +9 位作者 ziqi zhen Xiaoli Hu Xiang Li Fengxia Zhou Ying Liu Chuangeng Chen Shuangyu Xie Bailing Zhang Xiaoke Wu Zhiwei Huang 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2021年第5期1625-1625,共1页
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部